Blar i NTNU Open på forfatter "Falkmer, Ursula"
-
Adjuvant platinum-based chemotherapy in non-small cell lung cancer: The role of relative dose-intensity and treatment delay
Szejniuk, Weronika Maria; Cekala, M.; Bøgsted, Martin; Meristoudis, Christos; McCulloch, Tine; Falkmer, Ursula; Røe, Oluf Dimitri (Peer reviewed; Journal article, 2021)Background The study investigated the association of the relative dose-intensity (RDI) of cisplatin and timing of adjuvant platinum-based chemotherapy (APC) with survival for stage I-III non-small cell lung cancer (NSCLC) ... -
Effects of current parenteral nutrition treatment on health-related quality of life, physical function, nutritional status, survival and adverse events exclusively in patients with advanced cancer: A systematic literature review
Tobberup, Randi; Thoresen, Lene; Falkmer, Ursula; Yilmaz, Mette K.; Solheim, Tora Skeidsvoll; Balstad, Trude Rakel (Journal article; Peer reviewed, 2019)Background: The aim was to evaluate the effects of current parenteral nutrition (PN) treatment on clinical outcomes in patients with advanced cancer. Methods: This review was conducted according to the PRISMA guidelines ... -
Fractional exhaled nitric oxide as a potential biomarker for radiation pneumonitis in patients with non-small cell lung cancer: A pilot study
Szejniuk, Weronika Maria; Nielsen, Martin Skovmos; Brønnum, Dorthe; Takacs-Szabo, Z; Weinreich, Ulla Møller; Pilegaard Thomsen, L; Bøgsted, Martin; Jensen, Ingelise; McCulloch, Tine; Falkmer, Ursula; Carl, Jesper; Røe, Oluf Dimitri (Peer reviewed; Journal article, 2019)Introduction The aim of the study was to investigate repetitive fractional exhaled nitric oxide (FeNO) measurements during high-dose radiation therapy (HDRT) and to evaluate the use of FeNO to predict symptomatic radiation ... -
Identifying metabolic alterations in newly diagnosed small cell lung cancer patients
Pedersen, Shona; Hansen, Joachim Bavnhøj; Maltesen, Raluca Georgiana; Szejniuk, Weronica Maria; Andreassen, Trygve; Falkmer, Ursula; Kristensen, Søren Risom (Peer reviewed; Journal article, 2021)Background Small cell lung cancer (SCLC) is a malignant disease with poor prognosis. At the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is based on imaging, histopathology, and ...